Controversial obesity drug up to be debated at Kildare talk
Dr Andrew Hogan, from Maynooth University's Biology Department
Maynooth University is to host a panel discussion on one of the most talked-about drugs in society Ozempic, on Thursday, 14 November from 7pm to 9pm.
Titled ‘Ozempic – unravelling fact from fiction’, this panel event is open to the public and will take place in The Phoenix building, First Floor Mezzanine, on the North Campus.
Hosted as part of Science Week 2024 at Maynooth University, the discussion will explore the science behind the drug that has prompted questions, misunderstandings and myths.
Two leading experts in obesity research will lead the discussion - Dr Andrew Hogan, Senior Lecturer at the Department of Biology at MU, and Principal Investigator with the Obesity Immunology Research Group, and Prof Donal O'Shea, Consultant Endocrinologist with the Obesity Immunology Research Group at St Vincent’s University Hospital.
Together, they will explore the science behind Ozempic, including how it works and its impact on health.
Using the latest research, they will discuss how these medications have changed the way obesity is treated, and will also address questions as whether it causes muscle loss, or increase fertility.
Hosted by the Development and Alumni Relations Office, in collaboration with the Faculty of Science and Engineering, this public event also on livestream, offers an opportunity to gain expert insights and separate fact from fiction on one of today's most talked-about medications. Tickets are free, but limited at Eventbrite.ie
Dr Andrew Hogan joined Maynooth University as an Assistant Professor in 2017, and is Principal Investigator with the Obesity Immunology Research Group.
He completed his undergraduate and post-graduate studies in Maynooth University, before being awarded a Newman Fellowship in Obesity with Prof Donal O'Shea in UCD and St Vincent's Hospital. In 2012, he was awarded a Research Fellowship from the National Children's Research Centre and established the Childhood Obesity Immunology Group.
He has also been a research fellow in the lab of Prof Lydia Lynch in Harvard Medical School.
Dr Hogan is an alumnus of Maynooth having completed his undergraduate and postgraduate studies at the University.
Prof Donal O’ Shea graduated from UCD in 1989, and is a Consultant Endocrinologist at St. Vincent’s, HSE National Clinical Lead for Obesity and Consultant Endocrinologist of The Obesity Immunology Research group.
